The 2026 Best Firms to Work are not afraid to put their money where their mouths are, from holiday bonuses and work anniversary gifts, to sales rewards and new hire referral bonuses.
Energy sector profits that swelled alongside global conflicts are “morally unjustifiable” and should face additional taxes to fund climate measures, according to United Nations Secretary-General António Guterres.
AI has largely been presented as a tool: something a person opens, prompts and operates. But after running a head-to-head experiment with a tax firm, we found for recurring tasks a more useful frame is AI as a hire.
November 19 will mark the final day that people will be able to file information returns through the IRS FIRE system, as it will be permanently retired and replaced with the IRIS system instead.
Addex Therapeutics spinout Neurosterix will use the series B funds to advance an oral drug targeting M4, a muscarinic receptor also targeted by BMS’ Cobenfy, which introduced a new mechanism for treating schizophrenia with its 2024 approval.
With 10 active or planned Phase 3 trials underway for Metsera’s berobenatide, Pfizer has signed a deal with Blackstone Life Sciences to finance the program to approval.
October marked the first time this year there was an increase in both the number of biotech and pharma companies trimming their workforces and the number of affected employees when compared to 2025. Still, it’s highly unlikely 2026 layoffs will come close to matching the downsizing seen last year.